Glasgow Caledonian University

PhD Research Project Opportunity

Please note that as this project is not funded by a University studentship, the successful candidate will be required to source external funding for the research degree fees and living expenses while studying at the university.

Project Reference number / 2014SHLS002
School/Institute/Research Group /
  • School of Health and Life Science
  • Institute of Applied Health Research
  • Applied Vision Research

Research Discipline areas / cholesterol, age related macular degeneration, therapy
Research Theme / Visual Neuroscience, retinal degeneration
Project Title / The functional role of cholesterol trafficking in the pathogenesis of age related macular degeneration
Research Project Area / Age-related macular degeneration (AMD) is the commonest cause of blind registration in the developed world. Early AMD is characterized by drusen formation and pigmentary changes. Late AMD is characterized by Geographic atrophy and/or choroidal neovascularisation. An important pathological feature of AMD is the accumulation of both focal (drusen) and diffuse extracellular (basal) deposits in the macula, between the retinal pigment epithelium (RPE) and the adjacent Bruch's membrane. These deposits lead to dysfunction and later death of RPE and associated photoreceptors.Histopathological analyses of AMD patients’ eyes have demonstrated the appearance of apolipoproteins, cholesterol and cholesteryl ester deposits underneath RPE, suggesting abnormal cholesterol transport in disease progression. Recent genome wide association studies have also showed the hepatic lipase C (LIPC) and cholesterylester transfer protein (CETP), key genes involved in the metabolism of triglycerides and high-density lipoproteins (HDL), were implicated in the pathogenesis of AMD.
In this project we plan to investigate the functional role of effective cholesterol efflux in the pathogenesis of AMD and to develop small molecules to reverse the accumulation of cholesterol within RPE and choroidal endothelial cells, which will help to treat the early stages of AMD.
Supervisory Team /
  • Dr Xinhua Shu (Director of Studies, Visual Neuroscience Research Group)
  • Professor Ann Graham(Diabetes Research Group)

Staff Contact /
  • Dr Xinhua Shu,